Newlink Genetics Corporation

NLNK

Statistics

$8.58Share Price
$257 MMarket Cap
N/AEBIT / EV
N/AFCF / EV
N/AROIC
N/ACash ROIC
5194.2%3yr Avg Revenue Growth
5.14Current Ratio
star logo

Business Model Diligence

We do not yet have Business Model Diligence for this stock.

Statistical Diligence

x mark Cannot calculate EBIT / Enterprise Value, company has negative EBIT.
x mark Cannot calculate Free Cash Flow / Enterprise Value, company has negative Free Cash Flow.
x mark Cannot calculate Return on Invested Capital, company has negative EBIT.
x mark Cannot calculate Cash Return on Invested Capital, company has negative Free Cash Flow.
check mark The 3 Year Average Revenue Growth Value of 5194.2% ranks as Suspicious.
check mark Near-term Financial Health appears to be Very Good. The Current Ratio is 5.14.

Company Description

NewLink Genetics Corp. is a clinical stage immuno-oncology company, which focuses on discovering, developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians. Its portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. The company's products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189 and IDO Pathway Inhibitors. NewLink Genetics was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA.

Calculations

You must have a MagicDiligence Membership to view the Calculations for this stock. If you are already a member, you need to log in first.
Tracking Portfolios
blue wand Magic Recipe 29.36%
purple wand Deep Value 24.71%
orange wand Quality Growth 44.22%
green wand Green Team 6.14%
red dot Red Rating 5.76%
yellow dot Yellow Rating 14.17%
green dot Green Rating 14.95%
New Spell Stocks
blue wand Vector Group Ltd. (VGR)
purple wand New Stocks Added!